In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 6183352)

Published in J Immunol on January 01, 1983

Authors

H M Gebel, J R Scott, C A Parvin, G E Rodey

Articles citing this

T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. J Exp Med (2000) 1.30

Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Clin Exp Immunol (1987) 1.11

Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis. Clin Exp Immunol (1990) 1.03

The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest (1989) 1.02

The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes. Infect Immun (1999) 0.96

Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects. J Clin Invest (1983) 0.95

Identification of the principal T lymphocyte-stimulating antigens of Pseudomonas aeruginosa. J Exp Med (1984) 0.92

Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes. Infect Immun (1998) 0.80

Elimination of T-cell-receptor beta-chain diversity in transgenic mice restricts antigen-specific but not alloreactive responses. Immunology (1997) 0.78

Enhanced responsiveness to antigen contributes more to immunological memory in CD4 T cells than increases in the number of cells. Immunology (2005) 0.78

High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis. J Neuroimmunol (2007) 0.77

Induction of in vitro autoimmune responses by mononuclear blood cells in Hashimoto's thyroiditis. Clin Exp Immunol (1987) 0.75

Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay. PLoS One (2017) 0.75

Articles by these authors

Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor. J Biol Chem (1986) 6.38

Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol (1991) 4.99

Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09

A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81

An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol (1993) 3.76

Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69

Phage Pl cryptic. II. Location and regulation of prophage genes. Virology (1973) 3.63

Regulation of plasmid replication. Microbiol Rev (1984) 3.55

Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45

Genetic manipulation of pathogenic streptococci. Methods Enzymol (1991) 3.34

Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet (1987) 3.32

Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23

Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A (1984) 3.14

Excision and insertion of the conjugative transposon Tn916 involves a novel recombination mechanism. Cell (1989) 2.91

Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci U S A (1987) 2.90

Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89

Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66

A plasmid-encoded regulatory gene, rns, required for expression of the CS1 and CS2 adhesins of enterotoxigenic Escherichia coli. Proc Natl Acad Sci U S A (1989) 2.62

Expression of streptococcal M protein in Escherichia coli. Science (1983) 2.57

A turbid plaque-forming mutant of phage P1 that cannot lysogenize Escherichia coli. Virology (1974) 2.47

TUBERCULOSIS OF THE APPENDIX. Ann Surg (1917) 2.44

Genetic studies on bacteriophage P1. Virology (1968) 2.43

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A (1985) 2.24

Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20

Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol (1991) 2.17

Is vaginal birth after cesarean less expensive than repeat cesarean delivery? Am J Obstet Gynecol (2000) 2.09

Role of M protein in adherence of group A streptococci. Infect Immun (1991) 2.05

Obstetric complications associated with the lupus anticoagulant. N Engl J Med (1985) 2.05

Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03

A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA (1995) 2.02

Pharmaceutical history and its sources in the Wellcome collections. 3. Fluid medicines, prescription reform and posology 1700-1900. Med Hist (1970) 2.01

Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl Environ Microbiol (1998) 1.96

Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes. Infect Immun (1995) 1.95

Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85

Integration of the plasmid prophages P1 and P7 into the chromosome of Escherichia coli. J Mol Biol (1979) 1.83

Effect of psychoprophylaxis (Lamaze preparation) on labor and delivery in primiparas. N Engl J Med (1976) 1.80

Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun (1995) 1.78

Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. J Bacteriol (1995) 1.70

Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun (1997) 1.68

Combining laboratory data sets from multiple institutions using the logical observation identifier names and codes (LOINC). Int J Med Inform (1998) 1.67

Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation. Immunol Rev (1979) 1.64

Conformational characteristics of the complete sequence of group A streptococcal M6 protein. Proteins (1988) 1.62

Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62

Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58

A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4. Infect Immun (1989) 1.58

Acquisition of iron from host proteins by the group A streptococcus. Infect Immun (1996) 1.54

Evaluation of the TAS analyzer and the low-range heparin management test in patients undergoing extracorporeal membrane oxygenation. Clin Chem (2001) 1.53

Gene encoding the major subunit of CS1 pili of human enterotoxigenic Escherichia coli. Infect Immun (1990) 1.53

Introduction of the emm6 gene into an emm-deleted strain of Streptococcus pyogenes restores its ability to resist phagocytosis. Res Microbiol (1993) 1.48

Maternal thrombocytopenia in pregnancy: time for a reassessment. Am J Obstet Gynecol (1995) 1.46

Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun (2000) 1.45

Proinflammatory events and HLA antibodies: nothing to sneeze at. Am J Transplant (2009) 1.43

Solid-phase assays for the detection of alloantibody against human leukocyte antigens: panacea or Pandora? Int J Immunogenet (2014) 1.43

Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum (1980) 1.42

A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun (1987) 1.40

Rns, a virulence regulator within the AraC family, requires binding sites upstream and downstream of its own promoter to function as an activator. Mol Microbiol (2000) 1.38

Major flame burn caused by electric fly-swatter. J Burns Wounds (2007) 1.38

Privacy and publication. Obstet Gynecol (2001) 1.38

Transplanting the highly sensitized patient: The emory algorithm. Am J Transplant (2006) 1.38

A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood (1976) 1.38

Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J Pediatr (1969) 1.37

A rns-like regulatory gene for colonization factor antigen I (CFA/I) that controls expression of CFA/I pilin. Infect Immun (1990) 1.37

The in vitro response to phytohemagglutinin of lyphoid cells from normal and neonatally thymectomized adult mice. Int Arch Allergy Appl Immunol (1969) 1.35

Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect Immun (2001) 1.34

Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34

CooC and CooD are required for assembly of CS1 pili. Mol Microbiol (1994) 1.32

Photosynthetic carbon metabolism of a marine grass. Plant Physiol (1976) 1.31

New tools in an old trade: CS1 pilus morphogenesis. Mol Microbiol (1998) 1.30

Regulation of rns, a positive regulatory factor for pili of enterotoxigenic Escherichia coli. J Bacteriol (1994) 1.29

Clear plaque mutants of phage P1. Virology (1970) 1.28

The presence of conjugative transposon Tn916 in the recipient strain does not impede transfer of a second copy of the element. J Bacteriol (1991) 1.28

Role of the conserved C-repeat region of the M protein of Streptococcus pyogenes. Mol Microbiol (1995) 1.28

Progressive loss in vitro of cellular immunity with ageing in strains of mice susceptible to autoimmune disease. Clin Exp Immunol (1971) 1.28

Binding site recognition by Rns, a virulence regulator in the AraC family. J Bacteriol (1999) 1.27

Defective bactericidal activity of monocytes in fatal granulomatous disease. Blood (1969) 1.27

Germinal center T cells are distinct helper-inducer T cells. Hum Immunol (1991) 1.25

Streptococcal M protein size mutants occur at high frequency within a single strain. J Exp Med (1986) 1.25

Using Logical Observation Identifier Names and Codes (LOINC) to exchange laboratory data among three academic hospitals. Proc AMIA Annu Fall Symp (1997) 1.25

Assembly proteins of CS1 pili of enterotoxigenic Escherichia coli. Mol Microbiol (1996) 1.25

A secondary RNA polymerase sigma factor from Streptococcus pyogenes. Mol Microbiol (2001) 1.24

Regulation of mga transcription in the group A streptococcus: specific binding of mga within its own promoter and evidence for a negative regulator. J Bacteriol (1999) 1.23

Regulation of excision of the conjugative transposon Tn916. Mol Microbiol (1999) 1.22

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol (1992) 1.21

Hypoxia reduces expression and function of system A amino acid transporters in cultured term human trophoblasts. Am J Physiol Cell Physiol (2002) 1.20

A new gene controlling lysogeny in phage P1. Virology (1972) 1.20

Identification of isp, a locus encoding an immunogenic secreted protein conserved among group A streptococci. Infect Immun (1996) 1.19

Excision of a conjugative transposon in vitro by the Int and Xis proteins of Tn916. Nucleic Acids Res (1997) 1.18

DNA binding by the Xis protein of the conjugative transposon Tn916. J Bacteriol (1997) 1.18

Relationships between temperate phages Mu and P1. Virology (1978) 1.17

Conjugative transposition of Tn916: the transposon int gene is required only in the donor. J Bacteriol (1992) 1.17

Isolation and characterization of cloned fragments of bacteriophage P1 DNA. Virology (1979) 1.17

Novel group of virulence activators within the AraC family that are not restricted to upstream binding sites. Infect Immun (2001) 1.16

Correlative light and electron microscopy studies of PrP localisation in 87V scrapie. Brain Res (1994) 1.16

Iron starvation causes release from the group A streptococcus of the ADP-ribosylating protein called plasmin receptor or surface glyceraldehyde-3-phosphate-dehydrogenase. Infect Immun (1996) 1.15

Alternative complement pathway activity in sera from patients with sickle cell disease. Clin Exp Immunol (1976) 1.15

Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans. J Clin Invest (1985) 1.14

Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants. Lancet (1969) 1.14

Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14